The amazing osteocyte

Abstract

The last decade has provided a virtual explosion of data on the molecular biology and function of osteocytes. Far from being the “passive placeholder in bone,” this cell has been found to have numerous functions, such as acting as an orchestrator of bone remodeling through regulation of both osteoclast and osteoblast activity and also functioning as an endocrine cell. The osteocyte is a source of soluble factors not only to target cells on the bone surface but also to target distant organs, such as kidney, muscle, and other tissues. This cell plays a role in both phosphate metabolism and calcium availability and can remodel its perilacunar matrix. Osteocytes compose 90% to 95% of all bone cells in adult bone and are the longest lived bone cell, up to decades within their mineralized environment. As we age, these cells die, leaving behind empty lacunae that frequently micropetrose. In aged bone such as osteonecrotic bone, empty lacunae are associated with reduced remodeling. Inflammatory factors such as tumor necrosis factor and glucocorticoids used to treat inflammatory disease induce osteocyte cell death, but by different mechanisms with potentially different outcomes. Therefore, healthy, viable osteocytes are necessary for proper functionality of bone and other organs. © 2011 American Society for Bone and Mineral Research.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 112

1. 1.

   Recklinghausen FV. Untersuchungen uber Rachitis und Osteomalacia. 1920.

   Not in our library

2. 2.

   Belanger LF, Robichon J. Parathormone-induced osteolysis in dogs: a microradiographic and alpharadiographic survey. J Bone Joint Surg Am. 1964;46:1008-1012.

   Not in our library

3. 3.

   Belanger LF. Osteocytic osteolysis. Calcif Tissue Res. 1969;4:1-12.

   Not in our library10.1007/bf02279101

4. 4.

   Baylink DJ, Wergedal JE. Bone formation by osteocytes. Am J Physiol. 1971;221:669-678.

   Not in our library10.1152/ajplegacy.1971.221.3.669

5. 5.

   Pead MJ, Suswillo R, Skerry TM, Vedi S. Lanyon LE. Increased 3H-uridine levels in osteocytes following a. single short period of dynamic bone loading in vivo. Calcif Tissue Int. 1988;43:92-96.

   Not in our library10.1007/bf02555153

6. 6.

   Marotti G, Cane V, Palazzini S, Palumbo C. Structure-function relationships in the osteocyte. Ital. J. Min. Electrolyte Metab. 1990;4:93-106.

   Not in our library

7. 7.

   van der Plas A, Nijweide PJ. Isolation and purification of osteocytes. J Bone Miner Res. 1992;7:389-396.

   Not in our library10.1002/jbmr.5650070406

8. 8.

   Tanaka K, Matsuo T, Ohta M, et al. Time-lapse microcinematography of osteocytes. Miner Electrolyte Metab. 1995;1995:189-192.

   Not in our library

9. 9.

   Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev. 2000;21:115-137.

   Not in our library10.1210/edrv.21.2.0395

10. 10.

    Parfitt AM, BK H. Bone-forming cells in Clinical Conditions. Bone. The Osteoblast and Osteocyte. 1990;1:351-429.

    Not in our library

11. 11.

    Franz-Odendaal TA, Hall BK, Witten PE. Buried alive: how osteoblasts become osteocytes. Dev Dyn. 2006;235:176-190.

    Not in our library10.1002/dvdy.20603

12. 12.

    Barragan-Adjemian C, Nicolella D, Dusevich V, Dallas MR, Eick JD, Bonewald LF. Mechanism by which MLO-A5 late osteoblasts/early osteocytes mineralize in culture: similarities with mineralization of lamellar bone. Calcif Tissue Int. 2006;79:340-353.

    Not in our library10.1007/s00223-006-0107-2

13. 13.

    Holmbeck K, Bianco P, Pidoux I, et al. The metalloproteinase MT1-MMP is required for normal development and maintenance of osteocyte processes in bone. J Cell Sci. 2005;118:147-156.

    Not in our library10.1242/jcs.01581

14. 14.

    Zhao W, Byrne MH, Wang Y, Krane SM. Osteocyte and osteoblast apoptosis and excessive bone deposition accompany failure of collagenase cleavage of collagen. J Clin Invest. 2000;106:941-949.

    Not in our library10.1172/jci10158

15. 15.

    Holmbeck K, Bianco P, Caterina J, et al. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell. 1999;99:81-92.

    Not in our library10.1016/s0092-8674(00)80064-1

16. 16.

    Wetterwald A, Hoffstetter W, Cecchini MG, et al. Characterization and cloning of the E11 antigen, a marker expressed by rat osteoblasts and osteocytes. Bone. 1996;18:125-132.

    Not in our library10.1016/8756-3282(95)00457-2

17. 17.

    Schulze E, Witt M, Kasper M, Lowik CW, Funk RH. Immunohistochemical investigations on the differentiation marker protein E11 in rat calvaria, calvaria cell culture and the osteoblastic cell line ROS 17/2.8. Histochem Cell Biol. 1999;111:61-69.

    Not in our library10.1007/s004180050334

18. 18.

    Schwab W, Schulze E, Witt M, Funk RH, Kasper M. Immunohistochemical localization of the differentiation marker E11 in dental development of rats. Acta Histochem. 1999;101:431-436.

    Not in our library10.1016/s0065-1281(99)80043-9

19. 19.

    Zhang K, Barragan-Adjemian C, Ye L, et al. E11/gp38 selective expression in osteocytes: regulation by mechanical strain and role in dendrite elongation. Mol Cell Biol. 2006;26:4539-4552.

    Not in our library10.1128/mcb.02120-05

20. 20.

    Guo D, Zhao H, Mishina Y, Feng J, Harris S, Bonewald L. Mice with Targeted Deletion of E11/gp38 in Late Osteoblasts Have Reduced Canaliculi per Osteocyte Which May Be Responsible for The Enhanced Trabecular Bone Volume. FR0268. J Bone Min Res. 2009;S126.

    Not in our library

21. 21.

    Tanaka-Kamioka K, Kamioka H, Ris H, Lim SS. Osteocyte shape is dependent on actin filaments and osteocyte processes are unique actin-rich projections. J Bone Miner Res. 1998;13:1555-1568.

    Not in our library10.1359/jbmr.1998.13.10.1555

22. 22.

    Kamioka H, Sugawara Y, Honjo T, Yamashiro T, Takano-Yamamoto T. Terminal differentiation of osteoblasts to osteocytes is accompanied by dramatic changes in the distribution of actin-binding proteins. J Bone Miner Res. 2004;19:471-478.

    Not in our library10.1359/jbmr.040128

23. 23.

    Guo D, Keightley A, Guthrie J, Veno PA, Harris SE, Bonewald LF. Identification of osteocyte-selective proteins. Proteomics. 2010;10.

    Not in our library10.1002/pmic.201000306

24. 24.

    Okada S, Yoshida S, Ashrafi SH, Schraufnagel DE. The canalicular structure of compact bone in the rat at different ages. Microsc Microanal. 2002;8:104-115.

    Not in our library10.1017/s1431927601020037

25. 25.

    Mikuni-Takagaki Y, Kakai Y, Satoyoshi M, et al. Matrix mineralization and the differentiation of osteocyte-like cells in culture. J Bone Miner Res. 1995;10:231-242.

    Not in our library10.1002/jbmr.5650100209

26. 26.

    Qing H, Divieti Pajevic P, Barry K, Dusevich V, Wysolmerski J, Bonewald L. PTHR1 in Osteocytes Plays a Major role in Perilacunar Remodeling through the Activation of “Osteoclastic” Genes in Osteocytes. #1082J Bone Min Res. 2010;(Suppl):S25.

    Not in our library

27. 27.

    Tanaka K, Yamaguchi Y, Hakeda Y. Isolated chick osteocytes stimulate formation and bone-resorbing activity of osteoclast-like cells. Journal of Bone and Mineral Metabolism. 1995;13:61-70.

    Not in our library

28. 28.

    Zhao S, Zhang YK, Harris S, Ahuja SS, Bonewald LF. MLO-Y4 osteocyte-like cells support osteoclast formation and activation. J Bone Miner Res. 2002;17:2068-2079.

    Not in our library10.1359/jbmr.2002.17.11.2068

29. 29.

    Heino TJ, Hentunen TA, Vaananen HK. Osteocytes inhibit osteoclastic bone resorption through transforming growth factor-beta: enhancement by estrogen. J Cell Biochem. 2002;85:185-197.

    Not in our library10.1002/jcb.10109

30. 30.

    Heino TJ, Hentunen TA, Vaananen HK. Conditioned medium from osteocytes stimulates the proliferation of bone marrow mesenchymal stem cells and their differentiation into osteoblasts. Exp Cell Res. 2004;294:458-468.

    Not in our library10.1016/j.yexcr.2003.11.016

31. 31.

    Verborgt O, Tatton NA, Majeska RJ, Schaffler MB. Spatial distribution of Bax and Bcl-2 in osteocytes after bone fatigue: complementary roles in bone remodeling regulation? J Bone Miner Res. 2002;17:907-914.

    Not in our library10.1359/jbmr.2002.17.5.907

32. 32.

    Kogianni G, Mann V, Noble BS. Apoptotic bodies convey activity capable of initiating osteoclastogenesis and localized bone destruction. J Bone Miner Res. 2008;23:915-927.

    Not in our library10.1359/jbmr.080207

33. 33.

    Tatsumi S, Ishii K, Amizuka N, et al. Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. Cell Metab. 2007;5:464-475.

    Not in our library10.1016/j.cmet.2007.05.001

34. 34.

    Kramer I, Halleux C, Keller H, et al. Osteocyte Wnt/beta-catenin signaling is required for normal bone homeostasis. Mol Cell Biol. 2010;30:3071-3085.

    Not in our library10.1128/mcb.01428-09

35. 35.

    Weinstein RS, Nicholas RW, Manolagas SC. Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip. J Clin Endocrinol Metab. 2000;85:2907-2912.

    Not in our library10.1210/jcem.85.8.6714

36. 36.

    Dodd JS, Raleigh JA, Gross TS. Osteocyte hypoxia: a novel mechanotransduction pathway. Am J Physiol. 1999;277:C598-602.

    Not in our library10.1152/ajpcell.1999.277.3.c598

37. 37.

    Tomkinson A, Reeve J, Shaw RW, Noble BS. The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J Clin Endocrinol Metab. 1997;82:3128-3135.

    Not in our library10.1210/jcem.82.9.4200

38. 38.

    Emerton KB, Hu B, Woo AA, et al. Osteocyte apoptosis and control of bone resorption following ovariectomy in mice. Bone. 2010;46:577-583.

    Not in our library10.1016/j.bone.2009.11.006

39. 39.

    Bonewald L, Marcus DF R, Nelson D, Rosen C. Osteocytes. Osteoporosis. 2007;1:169-190.

    Not in our library

40. 40.
    Mechanical induction of PGE2 in osteocytes blocks glucocorticoid-induced apoptosis through both the β-catenin and PKA pathways · 2010

    No notice

Cited by papers we hold 47

• Significance of mechanical loading in bone fracture healing, bone regeneration, and vascularization · 2023
  No notice
• Bioactive Materials for Bone Regeneration: Biomolecules and Delivery Systems · 2023
  No notice
• Oxidative Stress and Natural Antioxidants in Osteoporosis: Novel Preventive and Therapeutic Approaches · 2023
  No notice
• Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities · 2022
  No notice
• Roles of the RANKL–RANK Axis in Immunity—Implications for Pathogenesis and Treatment of Bone Metastasis · 2022
  Not checked
• Engineered bone cement trigger bone defect regeneration · 2022
  Not checked
• Bone remodeling: an operational process ensuring survival and bone mechanical competence · 2022
  No notice
• Temporomandibular Joint Osteoarthritis: Pathogenic Mechanisms Involving the Cartilage and Subchondral Bone, and Potential Therapeutic Strategies for Joint Regeneration · 2022
  No notice
• Pulsed electromagnetic field (PEMF) transiently stimulates the rate of mineralization in a 3-dimensional ring culture model of osteogenesis. · 2021
  Not checked
• Uniaxially fixed mechanical boundary condition elicits cellular alignment in collagen matrix with induction of osteogenesis · 2021
  Not checked
• Control of phosphorus and prevention of fractures in the kidney patient · 2021
  Not checked
• Subchondral bone microenvironment in osteoarthritis and pain · 2021
  No notice
• Roles of mechanosensitive channel Piezo1/2 proteins in skeleton and other tissues · 2021
  No notice
• Intercellular mitochondrial transfer as a means of tissue revitalization · 2021
  No notice
• Osteoblast Differentiation and Signaling: Established Concepts and Emerging Topics · 2021
  No notice
• Update on the effects of microgravity on the musculoskeletal system · 2021
  No notice
• Human bone marrow stem/stromal cell osteogenesis is regulated via mechanically activated osteocyte‐derived extracellular vesicles · 2020
  Not checked
• Molecular mechanosensors in osteocytes · 2020
  No notice
• Molecular mechanisms and clinical management of cancer bone metastasis · 2020
  No notice
• Osteocyte-Related Cytokines Regulate Osteoclast Formation and Bone Resorption · 2020
  No notice

and 27 more

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.